Nuvothera
Manufacturing · Texas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1120 South Fwy, Fort Worth, Texas, 76104...Phone Number
(833) 776-7483Website
www.prosoria.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Nuvothera
Nuvothera, Inc. offers the Prosoria psoriasis treatment system, which is a clinically proven, once-daily, three-step regimen designed to relieve symptoms of psoriasis, including scaling, itching, and redness. Their product line includes a cream, moisturizer, and skin exfoliating ointment, aimed at providing powerful relief for those suffering from psoriasis. Additionally, they promote a turmeric supplement that supports healthy skin, hair, nails, and joints, as well as a healthy inflammatory response throughout the body. Nuvothera targets individuals seeking effective solutions for psoriasis and overall skin health.Explore more
Nuvothera Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nuvothera your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Nuvothera launches new products
Funding: Get notified immidiatlly once Nuvothera has new funding data
Earning: See what the market has to say on Nuvothera recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Nuvothera, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Nuvothera is spiking on competitors!
Click to see if Nuvothera had a recent Job posting/layoffs
Check if Nuvothera has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Nuvothera
Recommended Actions
Find VP level buyers at Nuvothera
Find 2 more new buyers
Compare Similar Companies to Nuvothera
Compare insights from companies similar to Nuvothera, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nuvothera is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nuvothera is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nuvothera.
Nuvothera Tech Stack
A closer look at the technologies used by Nuvothera
Nuvothera News & Media
DS Biopharma and Nuvothera Enter Option and License Agreement for EPADILIN®
DUBLIN, Ireland & FORT WORTH, Texas--(BUSINESS WIRE)--Nuvothera has acquired an option to exclusively licence rights to develop and commercialise DS Biopharma's EPADILIN® in the United States.Nuvothera's Prosoria Launches Improved Psoriasis Treatment System
FORT WORTH, Texas, Feb. 2, 2021 /PRNewswire/ -- Nuvothera, a Fort Worth, Texas-based biotech company, has launched an improved version of its revolutionary Prosoria psoriasis treatment system for this tough-to-treat skin condition. The new stream-lined, 2-step treatment is simpler than...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nuvothera
Sign Up For FreeTo access detailed company insights
Nuvothera, Inc. offers the Prosoria psoriasis treatment system, which is a clinically proven, once-daily, three-step regimen designed to relieve symptoms of psoriasis, including scaling, itching, and redness. Their product line includes a cream, moisturizer, and skin exfoliating ointment, aimed at providing powerful relief for those suffering from... Read More
